182 related articles for article (PubMed ID: 30766662)
1. A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy.
Yu Y; Li S; Wang K; Wan X
Comput Struct Biotechnol J; 2019; 17():136-141. PubMed ID: 30766662
[TBL] [Abstract][Full Text] [Related]
2. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
3. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
Grootjans JJ; Reekmans G; Ceulemans H; David G
J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
[TBL] [Abstract][Full Text] [Related]
4. Syntenin-targeted peptide blocker inhibits progression of cancer cells.
Liu J; Qu J; Zhou W; Huang Y; Jia L; Huang X; Qian Z; Xia J; Yu Y
Eur J Med Chem; 2018 Jun; 154():354-366. PubMed ID: 29857221
[TBL] [Abstract][Full Text] [Related]
5. Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target.
Pintor-Romero VG; Hurtado-Ortega E; Nicolás-Morales ML; Gutiérrez-Torres M; Vences-Velázquez A; Ortuño-Pineda C; Espinoza-Rojo M; Navarro-Tito N; Cortés-Sarabia K
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189651
[TBL] [Abstract][Full Text] [Related]
6. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor invasion: the roles of MDA-9/Syntenin.
Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
9. mda-9/Syntenin: a positive regulator of melanoma metastasis.
Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors against Two PDZ Domains of MDA-9 Suppressed Migration of Breast Cancer Cells.
Tang H; Wang L; Li S; Wei X; Lv M; Zhong F; Liu Y; Liu J; Fu B; Zhu Q; Wang D; Liu J; Ruan K; Gao J; Xu W
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834839
[TBL] [Abstract][Full Text] [Related]
12. PDZ tandem of human syntenin: crystal structure and functional properties.
Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
[TBL] [Abstract][Full Text] [Related]
13. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
[TBL] [Abstract][Full Text] [Related]
14. The binding of the PDZ tandem of syntenin to target proteins.
Grembecka J; Cierpicki T; Devedjiev Y; Derewenda U; Kang BS; Bushweller JH; Derewenda ZS
Biochemistry; 2006 Mar; 45(11):3674-83. PubMed ID: 16533050
[TBL] [Abstract][Full Text] [Related]
15. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
16. Different conformational dynamics of PDZ1 and PDZ2 in full-length EBP50 analyzed by hydrogen/deuterium exchange mass spectrometry.
Park JY; Duc NM; Kim DK; Lee SY; Li S; Seo MD; Woods VL; Chung KY
Biochem Cell Biol; 2015 Aug; 93(4):290-7. PubMed ID: 25789870
[TBL] [Abstract][Full Text] [Related]
17. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
[TBL] [Abstract][Full Text] [Related]
18. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
[TBL] [Abstract][Full Text] [Related]
20. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]